Authors' Reply to Chen and Chen : Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis"
| Errataetall: |
CommentOn: Am J Clin Dermatol. 2023 Sep;24(5):853-854. - PMID 38036747 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
American journal of clinical dermatology - 24(2023), 5 vom: 30. Sept., Seite 855-858 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yu, Chia-Ling [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 04.12.2023 Date Revised 07.12.2023 published: Print-Electronic CommentOn: Am J Clin Dermatol. 2023 Sep;24(5):853-854. - PMID 38036747 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s40257-023-00803-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36527867X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36527867X | ||
| 003 | DE-627 | ||
| 005 | 20231226101328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40257-023-00803-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1217.xml |
| 035 | |a (DE-627)NLM36527867X | ||
| 035 | |a (NLM)38036748 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yu, Chia-Ling |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Authors' Reply to Chen and Chen |b Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis" |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.12.2023 | ||
| 500 | |a Date Revised 07.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Am J Clin Dermatol. 2023 Sep;24(5):853-854. - PMID 38036747 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Isotretinoin |2 NLM | |
| 650 | 7 | |a EH28UP18IF |2 NLM | |
| 700 | 1 | |a Chou, Po-Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Chih-Sung |e verfasserin |4 aut | |
| 700 | 1 | |a Chiang, Li-Huei |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Tzu-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Tu, Yu-Kang |e verfasserin |4 aut | |
| 700 | 1 | |a Chi, Ching-Chi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of clinical dermatology |d 2000 |g 24(2023), 5 vom: 30. Sept., Seite 855-858 |w (DE-627)NLM11594981X |x 1179-1888 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:5 |g day:30 |g month:09 |g pages:855-858 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40257-023-00803-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 5 |b 30 |c 09 |h 855-858 | ||